E78.5
Conditions
Interventions
Group 1: Participants are test persons with elevated serum level of lp(a) > 50 mg/dl, without chronicl diseases and no regular medication. Blood samples are taken every month for the first year. Durin
Sponsors
Uniklinik Freiburg Abt. Klinische Chemie
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: lipoprotein(a) > 50 mg/dl, no relevant internal diseases, no permanent medication except oral contraceptives
Exclusion criteria
Exclusion criteria: relevant internal diseases, renal failure, liver failure, hypo-hyperthyreoidism, diabetes mellitus, hormone intake except oral contraceptives, permanent medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analysis of lipoprotein(a) serum levels. In the first year once every month, in the second year every third month. The study ends with the last blood sample taken. | — |
Secondary
| Measure | Time frame |
|---|---|
| In each blood sample (first year once a month, second year every third month) the following parameters are analysed: Cholesterol, Triglycerides, LDL-Cholesterol,VLDL-Cholesterol, HDL-Cholesterol, HDL- and LDL-subtypes, Creatinin,GGT, ALT, AST, Albumin, Cholinesterase,TSH, HbA1c, Lp-PLA2 and lp(a)-subtypes. In test persons who gave consent apo E and apo(a) genotype is analysed. | — |
Countries
Germany
Contacts
Public ContactBrigitte König
Abteilung Klinische Chemie und Lipidambulanz
Outcome results
None listed